Expressing support for continued investment to complete the development of an HIV vaccine.

HRES 1506 is a symbolic House resolution expressing support for continued government and private investment to develop an HIV vaccine. It does not create new funding or policy but encourages ongoing efforts to complete vaccine development, directly affecting public health advocates, researchers, and organizations working on HIV prevention. The resolution cites statistics on HIV disparities (e.g., Black Americans having 8.1x higher infection rates than White Americans) and current vaccine trials to underscore the need for sustained investment. It references existing U.S. funding for HIV/AIDS programs ($7.4 billion in FY2022) and emphasizes the potential public health benefits of a vaccine. The resolution serves as a statement of congressional encouragement, not a binding policy change.